DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ogungbenro K, Patel A, Duncombe R, Nuttall R, Clark J, Lorigan P.
Dose rationalization of pembrolizumab and nivolumab using pharmacokinetic modeling and simulation and cost analysis.
Clin Pharmacol Ther 2018;
103 (04) 582-590
We do not assume any responsibility for the contents of the web pages of other providers.